ACTC Lab presents abstracts at AACR Annual Meeting

14-18 April 2018, Chicago, Illinois, USA

A number of ACTC Lab members are presenting abstracts at the 109th American Association for Cancer Research (AACR) Annual Meeting in Chicago, Illinois.

All abstracts include the development of highly specific and sensitive liquid biopsy approaches for the detection of genetic and epigenetic alterations on Circulating Tumor Cells (CTCs) and circulating tumor DNA (ctDNA).

Tuesday, April 17, from 8:00 p.m. to 12:00 p.m.
Poster session # PO.CL10.09: Liquid Biopsies 3

#3655
DNA methylation analysis in liquid biopsy: A detailed study on quality control, sample storage and whole genome amplification procedures for downstream applications
Sofia Mastoraki, Maria Chimonidou, Eleni Tzanikou, Evi Lianidou

Tuesday, April 17, from 1:00 p.m. to 5:00 p.m.
Poster session # PO.CL10.10: Liquid Biopsies 4

#4576
Combination of a label independent CTC enrichment platform with fluorescence in situ hybridization for the molecular characterization of CTCs in non-small cell lung cancer patients
Aliki Ntzifa, Martha Zavridou, Pavlos Pollakis, Georgia Bardi, Vasilis Georgoulias, Athanasios Kotsakis, Evi Lianidou

#4577
ESR1 methylation: A liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment
Sofia Mastoraki, Areti Strati, Eleni Tzanikou, Maria Chimonidou, Eleni Politaki, Alexandra Voutsina, Amanda Psyrri, Vassilis Georgoulias, Evi Lianidou

#4587
ESR1 methylation in in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Lydia Giannopoulou, Sophia Mastoraki, Areti Strati, Isaam Chebouti, Sabine Kasimir-Bauer, Evi Lianidou

 

---